Announcements Trials

Browse Landscape

Status

Completed 33 Withdrawn 6 Unknown 2 Terminated 2 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Carcinoma, Medullary 1

Interventions

pembrolizumab 225 Cyclophosphamide 194 Radiotherapy 181 Nivolumab 181 Carboplatin 155 Paclitaxel 114 Cisplatin 113 Dexamethasone 111 Radiosurgery 103 Magnetic Resonance Spectroscopy 98 Surveys and Questionnaires 92 Ipilimumab 82 Doxorubicin 80 Lenalidomide 77 durvalumab 76 Rituximab 75 atezolizumab 73 Radiation 72 venetoclax 69 Standard of Care 69 fludarabine 68 Gemcitabine 67 Specimen Handling 65 Etoposide 64 Capecitabine 64 Bevacizumab 62 Docetaxel 60 Oxaliplatin 59 Biopsy 58 Radiotherapy, Intensity-Modulated 56

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × OTHER × In Situ Hybridization, Fluorescence × Clear all

NCT04970134 2024-09-19

MOLTHY

Grupo Español de Tratamiento de Tumores de Cabeza y Cuello

Active not recruiting

Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡